Clinical Trials Browser

Terminated × veltuzumab × Clear all

NCT01147393 2018-02-22

Combination Veltuzumab and Fractionated 90Y- Epratuzumab Radioimmunotherapy in Follicular Lymphoma

Phase 1/2 Terminated

4 enrolled 3 charts

Lymphoma, Follicular

NCT01390545 2016-04-13

VELVET

Phase 2 Terminated

Arthritis, Rheumatoid